Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
Clinical trial NCT03832998 · COMPLETED
Trial details
- NCT number
- NCT03832998
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-05
- Primary completion
- 2025-01-08
- Enrollment
- 284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.